Work

Clinical and histologic characterization of dermatologic adverse events from the pan-PI3K inhibitor buparlisib (BKM-120).

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.e20639

Authors: Katja Schindler, Ronnie Abraham, Payal Deepak Shah, Sarat Chandarlapaty, Paul K. Paik, Katherine Bell-McGuinn, Dean F. Bajorin, Ingo K. Mellinghoff, Anas Younes, Mrinal M. Gounder, Matthew G. Fury, Klaus J. Busam, Maura N. Dickler, Mario E. Lacouture

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Chemotherapy-related skin toxicity

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601769800

Cites:

Cited by: 5

Related to: 10